Skip to content

Bd Phoenix Automated Microbiology System Trimethoprim - Gn 0.5-16 Ug/Ml

by Becton, Dickinson & CO

510(k) K030986

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 6 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 6 Oct 2026. What this means

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK030986 Date16 May 2003ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 6 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
LON
Device Class
Class II
Regulation
21 CFR Part 866.1645
Advisory Committee
Microbiology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The BD Phoenix Automated Microbiology System Trimethoprim – GN 0.5–16 µg/ml is an automated system for in vitro antimicrobial susceptibility testing (AST) of Gram-negative bacteria. It evaluates microbial growth and response to antimicrobial agents, including trimethoprim, to support clinical decision-making in microbiology laboratories. The system is designed to provide rapid and automated detection of bacterial susceptibility patterns, aiding in the selection of appropriate antimicrobial therapy.

This device is intended for use in clinical microbiology laboratories and is supplied as a reusable instrument with disposable consumables, including AST panels. The system operates under non-sterile conditions for the instrument itself, though consumables may require sterile handling as specified by the manufacturer. It is classified as FDA Class II and has received a Traditional 510(k) clearance for antimicrobial susceptibility testing. The trimethoprim concentration range of 0.5–16 µg/ml is included in the Gram-negative AST panels for testing bacterial isolates.

Other devices from Becton, Dickinson & Co.

See all devices from Becton, Dickinson & Co. →

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What types of bacteria does this device test for susceptibility to trimethoprim, and how does it help in clinical decision-making?

    This device tests Gram-negative bacteria for antimicrobial susceptibility to trimethoprim, with a concentration range of 0.5–16 µg/ml. It automates the detection of bacterial growth and response to antimicrobial agents, providing rapid results to help clinicians select the most effective antimicrobial therapy for infections caused by these bacteria.

  • Is the BD Phoenix Automated Microbiology System itself single-use, or are there disposable components that need to be replaced?

    The BD Phoenix Automated Microbiology System is a reusable instrument, but it requires disposable consumables, specifically AST panels, for each use. These consumables may need sterile handling as directed by the manufacturer, though the instrument itself is not sterile.

  • What regulatory pathway was followed for this device’s clearance, and what class does it fall under?

    This device received a Traditional 510(k) clearance from the FDA and is classified as a Class II medical device. The clearance was based on a determination of substantial equivalence to a predicate device, as indicated by the 'decision_code: SESE' and 'clearance_type: Traditional' in the submission.

  • How does the automated testing process differ from traditional manual methods, and what advantages does it offer?

    Unlike traditional manual methods, the BD Phoenix Automated Microbiology System streamlines antimicrobial susceptibility testing (AST) by automating microbial growth detection and response evaluation. This reduces human error, speeds up results, and allows for consistent, rapid analysis of bacterial susceptibility to trimethoprim and other agents, improving efficiency in clinical microbiology labs.